Healthcare produces massive amounts of data, in health facilities, from medical devices, personal devices and sensors. Does all this data equate to improved access to care, more efficient care or better outcomes? What does it take to realize the benefits of data?

See how advances in technology, cognitive computing, smart connected devices, wearables and sensors, software platforms and new business partnerships, are transforming the way we discover, deliver and receive care and manage health and are already showing encouraging results.

Gladly introducing the Panel Chair:

Shmuley Goldberg, Director of Corporate Development – VCCC, Melbourne Health

Shmuley Goldberg is a pioneer in driving performance excellence and innovation in health systems, a digital health expert and former co-organizer of Health 2.0 in New York City. He advises startups, corporations and health systems on innovating in health and development of strategies to realize the power of data and digital health.

with Guest Speakers:

Dev Mookerjee, Senior Consultant – Business Analytics, IBM Australia

Dev Mookerjee leads the IBM Watson Solution Architects in Asia Pacific, GCC and Japan. As one of the first AP team members of the Watson group, Dev has a wealth of experience with Watson implementations in the region and helping organisations start their cognitive journeys. Prior to joining the Watson Group, Dev was a Global Technical Ambassador for IBM’s Social Media Analytics solution. With fifteen years experience in large scale Analytics deployments, Dev’s experience spans across all major industries, and he holds a Masters in IT from the University of Canberra and a MBA from Macquarie University.

Mr Ian Aitken, Director, Engineering and Solutions at Samsung Electronics

Ian Aitken was appointed Director of Pre-Sales, Solutions and ISV Partners, Enterprise and Small & Medium Business, for Samsung Electronics Australia in November 2014.
An industry veteran, Ian brings with him over 24 years of ICT (Information and Communication Technology) experience with global companies including Lucent Technologies, Concerto and Cisco.
In Samsung, Ian is tasked to leverage on the company’s success in consumer electronics to break new ground for its Enterprise and SMB (Small & Medium Business) businesses. His vision is to build strong relationships with Enterprises to develop new ways of using Samsung technologies to bring about business transformation.
Prior to his appointment at Samsung, Ian spent 13 years in several leadership roles in Cisco, including APCJ Director of Engineering of Cisco’s Global Enterprise Theatre.
Mr. Aitken studied electronic engineering in Australia at Royal Melbourne Institute of Technology University (RMIT) and is a passionate technology evangelist and avid follower of good quality music. Informally studied human psychology and early childhood development. Ian is keenly interested in helping and developing people communicate better, interact better and develop human relationships.

Dr Michelle Ananda-Rajah FRACP PhD, Consultant Physician, Alfred Hospital

Michelle is a consultant physician in general medicine and infectious diseases at the Alfred Hospital, Melbourne with research interests in the clinical epidemiology of invasive fungal infections affecting patients with cancer or transplant recipients, antifungal drug stewardship and the role of data analytics in making surveillance of fungal infections feasible for hospitals.

Phil Goebel, CEO & Co-Founder, Quanticare Technologies

Philip Goebel is the CEO and co-founder of Quanticare Technologies, a startup health technology company building novel tracking and monitoring solutions to empower health professionals to deliver more proactive and preventative care using data. He is a graduate of the doctor of physiotherapy program at Melbourne University and was a 2014 Melbourne University entrepreneurial fellow. Along with the Quanticare Team, he won the 2014 Janssen Health and Technology Challenge for his innovative work on building a low cost sensor for walking frames to prevent falls in the elderly.

Dr James Dromey, Head of Commercialisation & Legal, Murdoch Childrens Research Institute

James is Head of Commercialisation & Legal at the Murdoch Childrens Research Institute, where he leads the development and commercialisation of a pipeline of more than 400 projects across drugs, devices, diagnostics and digital health. James championed the Murdoch Children’s drive into digital health and has positioned the institute as an international leader in this area. He led the development and implementation of a new model in medical research that facilitates greater collaboration and knowledge transfer across health and technology, engineering and ICT sectors. James has over 17 years experience in health and medical research, both as a research scientist and in technology innovation and commercialisation. Previously, James was Business Development Manager at the Walter & Eliza Hall Institute in Melbourne, where he led a number of strategic collaborations with industry partners ranging from SMEs, to top 5 international pharmaceutical, and Fortune 500 companies. As a research scientist he was part of a team that developed a first-in-class vaccine for celiac disease that went on to raise over $30 million and is now in clinical trials. His work has resulted in the filing of three patent applications, two of which have been commercialised.

Murdoch Childrens Research Institute
The Cox/Walford Meeting Room, Level 5, MCRI (Murdoch Childrens Research Institute), Royal Children’s Hospital, Flemington Road, Parkville, Victoria 3052